Policies and practice of solid organ donation amongst people living with HIV in Canada: time for education and re-evaluation

Branka VulesevicDarren LauscherDeepali KumarRuth Sapir-PichhadzeJean TchervenkovJonathan B. AngelCameron WolfeCecilia T. Costiniuka Division of Infectious Diseases and Chronic Viral Illnesses Service,McGill University Health Centre,Montreal,QC,Canadab CIHR Canadian HIV Trials Network,University of British Columbia,Vancouver,BC,Canadac Ajmera Transplant Centre,University Health Network,Toronto,ON,Canadad Centre for Outcomes Research and Evaluation,Research Institute of McGill University Health Centre,Montreal,QC,Canadae Department of Epidemiology,Biostatistics,Occupational Health,McGill University,Montreal,QC,Canadaf Division of Nephrology,Department of Medicine,McGill University,Montreal,QC,Canadag Multiorgan Transplant Program,Departments of Medicine and Surgery,McGill University Health Centre,Montreal,QC,Canadah Division of Experimental Medicine,McGill University Health Centre,Montreal,QC,Canadai Division of Infectious Diseases,Ottawa Hospital-General Campus,Ottawa,ON,Canadaj Division Division of Transplant Infectious Diseases,Department of Medicine,Duke University Medical Center,Durham,NC,USA

DOI: https://doi.org/10.1080/25787489.2024.2323848

2024-03-29

HIV Research & Clinical Practice

Abstract:The numbers of organ donors in Canada and the USA fall short of increasing demand, resulting in increased morbidity, poor health outcomes, higher medical costs and death of many individuals waitlisted for transplantation. In the US, since 2013 when the US HIV Organ Policy Equity (HOPE) Act lifted the ban on organ donation between people living with HIV, the option of using organs from People with HIV became a reality. In Canada, HIV diagnosis was an exclusion criterion to organ donation until 2017, when permission was granted if requirements for 'exceptional distribution' could be met. Still, donation of organs from people with HIV poses challenges. Herein, we overview policies involving donors with HIV in Canada in order to inform healthcare providers, researchers and the community. We also advocate for the need to reassess these policies, highlight educational needs and engage interest in advancing research to inform policy reforms.

pharmacology & pharmacy,infectious diseases